Low dose naltrexone

Low dose naltrexone (LDN), where naltrexone is used in doses approximately one-tenth those used for drug/alcohol rehabilitation purposes, is being used as an "off-label" treatment for certain immunologically-related disorders. The use of LDN for such diseases as cancer was discovered and developed by Ian Zagon, PhD in animal and in vitro research, and LDN's broader...
Read article at Wikipedia
Edit and Show details

Add or delete facts, expose empty fields, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Flag this Topic
Why do you want to flag this topic?
Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for this topic was automatically generated from the Wikipedia article "Low dose naltrexone" licensed under the GNU Free Documentation License .
Learn more about Freebase licensing and attribution